Table 3 Therapy received by the 22 patients in the French Barth syndrome cohort
From: Natural history of Barth syndrome: a national cohort study of 22 patients
Medications | n (%) |
|---|---|
ACE-I | 16 (72.7%) |
β-Blockers | 9 (40.9%) |
Digoxin | 11 (50%) |
Diuretics | 17 (77.3%) |
Anticoagulants | 5 (22.7%) |
Aspirin | 5 (22.7%) |
Antibiotic prophylaxis | 4 (18.2%) |
GCSF | 6 (27.2%) |
Other therapies | 12 (54.5%) |
22 (100%) |